AS

Arpit Sanjaybhai Oza

Active Director Director DIN 11627709
DIN 11627709 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Arpit Sanjaybhai Oza

Data last updated:

Arpit Sanjaybhai Oza is a Director at Aurika Pharmaceuticals Private Limited (since 2026).

DIN 11627709
Primary Designation Director
First Appointment 06 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20262026Active

Directorship timeline

Open interactive timeline →
Aurika Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arpit Sanjaybhai Oza

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Sanjaybhai Oza

Arpit Sanjaybhai Oza currently holds 1 directorship: Aurika Pharmaceuticals Private Limited (Director, since 06 Apr 2026).

Arpit Sanjaybhai Oza was first appointed on 06 Apr 2026 as Director at Aurika Pharmaceuticals Private Limited.

The current boards of Arpit Sanjaybhai Oza's companies include Ajay Ishvarbhai Prajapati (Aurika Pharmaceuticals Private Limited), Jaya Keyurkumar Prajapati (Aurika Pharmaceuticals Private Limited), Jigneshbhai Pramukhbhai Patel (Aurika Pharmaceuticals Private Limited), Kamalkumar Dasharathlal Patel (Aurika Pharmaceuticals Private Limited), Moradiya Yash Manishbhai (Aurika Pharmaceuticals Private Limited), Shivam Vijaykumar Gupta (Aurika Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available